Kozak & Associates’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Hold
107
﹤0.01% 214
2026
Q1
$11.8K Hold
107
﹤0.01% 250
2025
Q4
$9.96K Hold
107
﹤0.01% 257
2025
Q3
$8.62K Hold
107
﹤0.01% 271
2025
Q2
$7.96K Buy
+107
New +$6.11K ﹤0.01% 261

Other funds holding ACLS

Kozak & Associates's ACLS Position: Q2 2026 in Review

Kozak & Associates held its Axcelis (ACLS) position steady in Q2 2026 at 107 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #214.

Kozak & Associates first reported a position in ACLS in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Kozak & Associates held 107 shares of Axcelis worth $19.1K as of Q2 2026.
  • Kozak & Associates left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #214 holding.
  • Kozak & Associates first reported a position in Axcelis in Q2 2025 and has held it in 5 quarters since.
  • 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.